Gary Gillheeney | Chief Executive Officer |
Tim Cunningham | Chief Financial Officer |
Ryan Zimmerman | BTIG |
Steven Lichtman | Oppenheimer |
Good morning, ladies and gentlemen, and welcome to the Second Quarter 2019 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions] Please note that this conference call is being recorded and that the recording will be available on the company’s website for replay shortly.
Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company’s filings with the Securities and Exchange Commission, including the item 1A Risk Factors of the company’s Form 10-K for the year ended December 31, 2018.
You are cautioned to not place undue reliance upon any forward-looking statements, which speak only as of the date made.
Although it may voluntarily do so from time to time, the company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the applicable securities laws.